170 related articles for article (PubMed ID: 38216684)
1. Nanoreceptors promote mutant p53 protein degradation by mimicking selective autophagy receptors.
Huang X; Cao Z; Qian J; Ding T; Wu Y; Zhang H; Zhong S; Wang X; Ren X; Zhang W; Xu Y; Yao G; Wang X; Yang X; Wen L; Zhang Y
Nat Nanotechnol; 2024 Apr; 19(4):545-553. PubMed ID: 38216684
[TBL] [Abstract][Full Text] [Related]
2. The PI3K/mTOR dual inhibitor NVP-BEZ235 stimulates mutant p53 degradation to exert anti-tumor effects on triple-negative breast cancer cells.
Cai J; Xia J; Zou J; Wang Q; Ma Q; Sun R; Liao H; Xu L; Wang D; Guo X
FEBS Open Bio; 2020 Apr; 10(4):535-545. PubMed ID: 32027103
[TBL] [Abstract][Full Text] [Related]
3. Proteasomal and autophagy-mediated degradation of mutp53 proteins through mitochondria-targeting aggregation-induced-emission materials.
Wang M; Yang Z; Song Y; Wei P; Ishiwme N; Wang L; Zhang H; Jing M; Gao M; Wen L; Zhang Y
Acta Biomater; 2022 Sep; 150():402-412. PubMed ID: 35931280
[TBL] [Abstract][Full Text] [Related]
4. A degradative detour for mutant TP53.
Vakifahmetoglu-Norberg H; Yuan J
Autophagy; 2013 Dec; 9(12):2158-60. PubMed ID: 24145670
[TBL] [Abstract][Full Text] [Related]
5. Turmeric toxicity in A431 epidermoid cancer cells associates with autophagy degradation of anti-apoptotic and anti-autophagic p53 mutant.
Thongrakard V; Titone R; Follo C; Morani F; Suksamrarn A; Tencomnao T; Isidoro C
Phytother Res; 2014 Dec; 28(12):1761-9. PubMed ID: 25044209
[TBL] [Abstract][Full Text] [Related]
6. Chaperone-mediated autophagy degrades mutant p53.
Vakifahmetoglu-Norberg H; Kim M; Xia HG; Iwanicki MP; Ofengeim D; Coloff JL; Pan L; Ince TA; Kroemer G; Brugge JS; Yuan J
Genes Dev; 2013 Aug; 27(15):1718-30. PubMed ID: 23913924
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of mutant p53 by a dietary-related compound phenethyl isothiocyanate inhibits tumor growth.
Aggarwal M; Saxena R; Sinclair E; Fu Y; Jacobs A; Dyba M; Wang X; Cruz I; Berry D; Kallakury B; Mueller SC; Agostino SD; Blandino G; Avantaggiati ML; Chung FL
Cell Death Differ; 2016 Oct; 23(10):1615-27. PubMed ID: 27258787
[TBL] [Abstract][Full Text] [Related]
8. CHIP promotes autophagy-mediated degradation of aggregating mutant p53 in hypoxic conditions.
Maan M; Pati U
FEBS J; 2018 Sep; 285(17):3197-3214. PubMed ID: 29953728
[TBL] [Abstract][Full Text] [Related]
9. Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition.
Cordani M; Oppici E; Dando I; Butturini E; Dalla Pozza E; Nadal-Serrano M; Oliver J; Roca P; Mariotto S; Cellini B; Blandino G; Palmieri M; Di Agostino S; Donadelli M
Mol Oncol; 2016 Aug; 10(7):1008-29. PubMed ID: 27118659
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of mutant p53 by capsaicin, the major constituent of peppers.
Garufi A; Pistritto G; Cirone M; D'Orazi G
J Exp Clin Cancer Res; 2016 Sep; 35(1):136. PubMed ID: 27599722
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide reactivates proteasome-dependent degradation of mutant p53 protein in cancer cells in part via enhanced expression of Pirh2 E3 ligase.
Yan W; Jung YS; Zhang Y; Chen X
PLoS One; 2014; 9(8):e103497. PubMed ID: 25116336
[TBL] [Abstract][Full Text] [Related]
12. Thiostrepton degrades mutant p53 by eliciting an autophagic response in SW480 cells.
Kalathil D; Prasad M; Chelladurai M; John S; Nair AS
J Cell Physiol; 2018 Oct; 233(10):6938-6950. PubMed ID: 29665004
[TBL] [Abstract][Full Text] [Related]
13. SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis.
Li D; Marchenko ND; Moll UM
Cell Death Differ; 2011 Dec; 18(12):1904-13. PubMed ID: 21637290
[TBL] [Abstract][Full Text] [Related]
14. Regulation of p53 stability as a therapeutic strategy for cancer.
Xu Z; Wu W; Yan H; Hu Y; He Q; Luo P
Biochem Pharmacol; 2021 Mar; 185():114407. PubMed ID: 33421376
[TBL] [Abstract][Full Text] [Related]
15. Precise pancreatic cancer therapy through targeted degradation of mutant p53 protein by cerium oxide nanoparticles.
Zhang H; Zhang W; Hu B; Qin X; Yi T; Ye Y; Huang X; Song Y; Yang Z; Qian J; Zhang Y
J Nanobiotechnology; 2023 Apr; 21(1):117. PubMed ID: 37005668
[TBL] [Abstract][Full Text] [Related]
16. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy.
Zhang X; Qi Z; Yin H; Yang G
Theranostics; 2019; 9(4):1096-1114. PubMed ID: 30867818
[TBL] [Abstract][Full Text] [Related]
17. Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53.
Zhang S; Zhou L; Hong B; van den Heuvel AP; Prabhu VV; Warfel NA; Kline CL; Dicker DT; Kopelovich L; El-Deiry WS
Cancer Res; 2015 Sep; 75(18):3842-52. PubMed ID: 26294215
[TBL] [Abstract][Full Text] [Related]
18. Molecular interplay between mutant p53 proteins and autophagy in cancer cells.
Cordani M; Butera G; Pacchiana R; Donadelli M
Biochim Biophys Acta Rev Cancer; 2017 Jan; 1867(1):19-28. PubMed ID: 27871965
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a Potent and Selective Degrader for USP7.
Pei Y; Fu J; Shi Y; Zhang M; Luo G; Luo X; Song N; Mi T; Yang Y; Li J; Zhou Y; Zhou B
Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202204395. PubMed ID: 35691827
[TBL] [Abstract][Full Text] [Related]
20. Dissecting the pathways that destabilize mutant p53: the proteasome or autophagy?
Choudhury S; Kolukula VK; Preet A; Albanese C; Avantaggiati ML
Cell Cycle; 2013 Apr; 12(7):1022-9. PubMed ID: 23466706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
